Literature DB >> 11348936

Heterogeneity of airway inflammation in persistent asthma : evidence of neutrophilic inflammation and increased sputum interleukin-8.

P G Gibson1, J L Simpson, N Saltos.   

Abstract

STUDY
OBJECTIVES: To identify the characteristics of airway inflammation in persistent asthma and to examine the role of neutrophilic inflammation in noneosinophilic persistent asthma.
METHODS: Nonsmoking adults (n = 56) with persistent asthma and healthy control subjects (n = 8) underwent hypertonic saline solution challenge and sputum induction. Selected sputum portions were dispersed with dithiothreitol and assayed for total cell count, cellular differential, supernatant eosinophil cationic protein (ECP), myeloperoxidase, and interleukin (IL)-8.
RESULTS: We identified two distinct inflammatory patterns. Typical eosinophilic inflammation occurred in 41% of subjects, whereas the remainder exhibited noneosinophilic asthma (59%). Both neutrophil percentage and absolute neutrophil counts were increased in subjects with noneosinophilic asthma (64%, 283 x 10(6)/mL) compared to eosinophilic asthma (14%, 41 x 10(6)/mL) and control subjects (34%, 49 x 10(6)/mL; p = 0.0001). Myeloperoxidase was elevated in both noneosinophilic (280 ng/mL) and eosinophilic groups (254 ng/mL) compared with control subjects (82 ng/mL; p = 0.002). Sputum IL-8 levels were highest in subjects with noneosinophilic asthma (45 ng/mL) compared to eosinophilic asthma (9.6 ng/mL) and control subjects (3.5 ng/mL; p = 0.0001). Neutrophils correlated with IL-8 levels (r = 0.72). ECP was highest in subjects with eosinophilic asthma (2,685 ng/mL) compared with noneosinophilic asthma (1,081 ng/mL) and control subjects (110 ng/mL; p = 0.0001).
CONCLUSION: Induced-sputum analysis in persistent asthma identifies two different inflammatory patterns. The most common pattern is noneosinophilic, associated with a neutrophil influx and activation, which may be mediated by IL-8 secretion. There is heterogeneity of airway inflammation in persistent asthma, which indicates differing mechanisms and may impact on treatment responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11348936     DOI: 10.1378/chest.119.5.1329

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  148 in total

Review 1.  CD4+ T-cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm.

Authors:  Kiyoshi Hirahara; Toshinori Nakayama
Journal:  Int Immunol       Date:  2016-02-12       Impact factor: 4.823

2.  Non-eosinophilic asthma and the innate immune response.

Authors:  Ian D Pavord
Journal:  Thorax       Date:  2007-03       Impact factor: 9.139

3.  Radical-containing particles activate dendritic cells and enhance Th17 inflammation in a mouse model of asthma.

Authors:  Pingli Wang; Paul Thevenot; Jordy Saravia; Terry Ahlert; Stephania A Cormier
Journal:  Am J Respir Cell Mol Biol       Date:  2011-04-14       Impact factor: 6.914

Review 4.  Chemokines and their receptors as potential targets for the treatment of asthma.

Authors:  C Palmqvist; A J Wardlaw; P Bradding
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

Review 5.  Targeted Therapy for Severe Asthma: Identifying the Right Patients.

Authors:  Kathy Low; Philip G Bardin
Journal:  Mol Diagn Ther       Date:  2017-06       Impact factor: 4.074

Review 6.  Allergic Respiratory Inflammation and Remodeling.

Authors:  Kawa A M Amin
Journal:  Turk Thorac J       Date:  2015-07-01

Review 7.  A tale of two cytokines: IL-17 and IL-22 in asthma and infection.

Authors:  Michelle L Manni; Keven M Robinson; John F Alcorn
Journal:  Expert Rev Respir Med       Date:  2013-12-10       Impact factor: 3.772

8.  ATP-binding cassette transporter 1 attenuates ovalbumin-induced neutrophilic airway inflammation.

Authors:  Cuilian Dai; Xianglan Yao; Boris Vaisman; Todd Brenner; Katharine S Meyer; Meixia Gao; Karen J Keeran; Gayle Z Nugent; Xuan Qu; Zu-Xi Yu; Pradeep K Dagur; J Philip McCoy; Alan T Remaley; Stewart J Levine
Journal:  Am J Respir Cell Mol Biol       Date:  2014-11       Impact factor: 6.914

Review 9.  Neutrophils in asthma.

Authors:  Ana L Macdowell; Stephen P Peters
Journal:  Curr Allergy Asthma Rep       Date:  2007-11       Impact factor: 4.806

10.  Interleukin 8 and susceptibility to coronary artery disease: a population genetics perspective.

Authors:  Konstantina Vogiatzi; Stavros Apostolakis; Vassilios Voudris; Sophia Thomopoulou; Georgios E Kochiadakis; Demetrios A Spandidos
Journal:  J Clin Immunol       Date:  2008-04-02       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.